Enrichment of CES1 Carriers in the Pharmacogenomics Anti-Platelet Intervention Study
Latest Information Update: 19 Jun 2023
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Atherosclerosis; Cardiovascular disorders; Coronary thrombosis; Ischaemic heart disorders; Myocardial infarction; Peripheral arterial occlusive disorders; Stroke; Unstable angina pectoris
- Focus Pharmacogenomic; Therapeutic Use
- 09 Mar 2023 Status changed from recruiting to completed.
- 24 Jan 2022 Planned End Date changed from 1 Dec 2021 to 1 Jul 2023.
- 24 Jan 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Mar 2023.